{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:12:04Z","timestamp":1788649924908,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Recent trials (e.g., SOUND, INSEMA) indicate that omitting SLNB in patients with small tumors, negative imaging, and favorable prognoses maintains outcomes, reduces complications, and improves quality of life (3,4). Specifically, the INSEMA trial demonstrated that patients who omitted SLNB experienced significantly lower rates of persistent lymphedema (1.8% vs. 5.7%), restriction of arm\/shoulder mobility (2.0% vs. 3.5%), and pain with arm\/shoulder movement (2.0% vs. 4.2%) compared to those undergoing SLNB. Consequently, guidelines now suggest omitting routine SLNB in elderly patients and those with very low-risk tumors(2). This review summarizes current evidence, eligible populations, theoretical rationale, controversies, and future directions regarding SLNB omission in early breast cancer management.<\/jats:p>","DOI":"10.3389\/fonc.2025.1598730","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:30:09Z","timestamp":1750311009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice"],"prefix":"10.3389","volume":"15","author":[{"given":"Tao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the axilla in early-stage breast cancer: ontario health (Cancer care ontario) and ASCO guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer \u2014 Primary results of the INSEMA trial","volume":"392","author":"Reimer","year":"2025","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"The Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40259-016-0162-9","article-title":"Trastuzumab in the treatment of breast cancer","volume":"30","author":"Maximiano","year":"2016","journal-title":"BioDrugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"viii707","DOI":"10.1093\/annonc\/mdy424.008","article-title":"IMpassion130: Results from a global, randomised, double-blind, phase III study of atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naive, locally advanced or metastatic triple-negative breast cancer (mTNBC)","volume":"29","author":"Schmid","year":"2018","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030807","article-title":"The impact of an incidental dose on axillary tumor control and toxicity in localized breast cancer: A retrospective analysis","volume":"14","author":"Schmitt","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10889","article-title":"Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation","volume":"105","author":"De Boniface","year":"2018","journal-title":"Br J Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1074477","article-title":"Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3332\/ecancer.2014.383","article-title":"Treatment plan for breast cancer with sentinel node metastasis","volume":"8","author":"Abreu","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"B15","unstructured":"NCCN clinical practice guidelines in oncology: breast cancer. Version 4.2025\n          \n          \n          \n          2025"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/jca.30386","article-title":"A nomogram predicting lymph node metastasis in T1 breast cancer based on the surveillance, epidemiology, and end results program","volume":"10","author":"Zhao","year":"2019","journal-title":"J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00007-3","article-title":"70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age","volume":"22","author":"Piccart","year":"2021","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"New Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071543","article-title":"Pretherapeutic imaging for axillary staging in breast cancer: A systematic review and meta-analysis of ultrasound, MRI and FDG PET","volume":"10","author":"Le Boulc\u2019h","year":"2021","journal-title":"J Clin Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-015-0404-2","article-title":"The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review","volume":"6","author":"Kuijs","year":"2015","journal-title":"Insights Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.23838\/pfm.2021.00079","article-title":"Predictive value of chest computed tomography for axillary lymph node metastasis in patients with breast cancer: A retrospective cohort study","volume":"5","author":"Kim","year":"2021","journal-title":"Precis Future Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0427","article-title":"Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools","volume":"25","author":"Marino","year":"2020","journal-title":"Oncologist"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030968","article-title":"State of the art in 2022 PET\/CT in breast cancer: A review","volume":"12","author":"Zhang-Yin","year":"2023","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12862","DOI":"10.1097\/MD.0000000000012862","article-title":"Liquid biopsy prediction of axillary lymph node metastasis, cancer recurrence, and patient survival in breast cancer","volume":"97","author":"Lee","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4055","article-title":"Parallel analyses of somatic mutations in plasma circulating tumor DNA (ctDNA) and matched tumor tissues in early-stage breast cancer","volume":"25","author":"Zhang","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/s12967-022-03724-w","article-title":"Noninvasive prediction of axillary lymph node status in breast cancer using promoter profiling of circulating cell-free DNA","volume":"20","author":"Guo","year":"2022","journal-title":"J Transl Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)","volume":"17","author":"van Roozendaal","year":"2017","journal-title":"BMC Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12885-022-09273-1","article-title":"No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial","volume":"22","author":"Jung","year":"2022","journal-title":"BMC Cancer"},{"key":"B29","unstructured":"Sentinel node biopsy vs observation after axillary PET examination\n          \n          \n            \n              Shao\n              Z\n            \n          \n          Clinical trial registration\n          \n          2020"},{"key":"B30","unstructured":"Management of the axilla in early-stage breast cancer: ontario health (Cancer care ontario) and ASCO guideline. Version 3\n          \n          \n          \n          2021"},{"key":"B31","unstructured":"AGO guidelines: breast cancer - therapy algorithms. Version 2024\n          \n          \n          \n          2024"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2414899","article-title":"Sentinel-lymph-node biopsy in early-stage breast cancer \u2014 Is it obsolete","volume":"392","author":"Morrow","year":"2025","journal-title":"New Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1598730\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:30:11Z","timestamp":1750311011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1598730\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":33,"alternative-id":["10.3389\/fonc.2025.1598730"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1598730","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"1598730"}}